Ferreira Karine, Kont Evant, Abdelkhalik Amira, Jones Dominic, Baker-Knight James
Novo Nordisk A/S Søborg Denmark.
Ipsos London UK.
Obes Sci Pract. 2024 Aug 14;10(4):e70000. doi: 10.1002/osp4.70000. eCollection 2024 Aug.
In many countries, obesity treatments are not fully reimbursed by healthcare systems. People living with obesity (PwO) often pay out-of-pocket (OOP) for pharmacological and non-pharmacological interventions, placing them in a position of financial risk to manage their condition. This study sought to understand the OOP expenditures and non-financial costs incurred by PwO to manage weight.
A 25-min cross-sectional online survey was conducted with PwO between ages 18-60 in Italy, Japan, India, Brazil, Spain and South Korea. Respondents were recruited using proprietary vendor panels and non-probability sampling. = 600 participants completed the survey ( = 100 per country).
The mean annual OOP expenditure related to weight loss/management was $7,351, accounting for nearly 17% of annual household income. Costs generally increased by BMI. Half or more of the respondents agreed that obesity affected multiple aspects of their lives (outside activities, running a household, social life, work, family life, traveling). 46% agreed that obesity limited their job prospects.
PwO spend a notable amount of their income paying OOP expenditures related to managing their weight. Quantifying the individual economic burden of living with obesity can inform the understanding of the resources required and policy changes needed to treat obesity as a disease.
在许多国家，医疗保健系统并未完全报销肥胖症治疗费用。肥胖症患者（PwO）通常需自掏腰包支付药物和非药物干预费用，这使他们在管理自身病情时面临经济风险。本研究旨在了解肥胖症患者管理体重的自付费用和非财务成本。
对意大利、日本、印度、巴西、西班牙和韩国18至60岁的肥胖症患者进行了一项25分钟的横断面在线调查。通过专有供应商面板和非概率抽样招募受访者。600名参与者完成了调查（每个国家100名）。
与减肥/体重管理相关的年均自付费用为7351美元，占家庭年收入近17%。费用通常随体重指数增加。半数或更多受访者认为肥胖影响了他们生活的多个方面（户外活动、家务、社交生活、工作、家庭生活、旅行）。46%的受访者认为肥胖限制了他们的就业前景。
肥胖症患者需花费相当一部分收入自掏腰包支付与体重管理相关的费用。量化肥胖症患者的个人经济负担有助于理解将肥胖症作为一种疾病进行治疗所需的资源和政策变化。
